Help keep Salon independent

Topic: Mylan

(Shutterstock)

Why the U.S. can't lower drugs prices

Shira Tarlo
The drug lobby is stepping up efforts to out-play Trump (AP)

Sydney Lupkin - KFF Health News
FILE - In this July 8, 2016, file photo, a pharmacist holds a package of EpiPens epinephrine auto-injector, a Mylan product, in Sacramento, Calif. Mylan said it will make available a generic version of its EpiPen, as criticism mounts over the price of its injectable medicine. (AP Photo/Rich Pedroncelli, File) (AP)

Matthew Rozsa
Senator and former Democratic presidential candidate Bernie Sanders speaks at the Democratic National Convention in Philadelphia, Pennsylvania, U.S. July 25, 2016. REUTERS/Mike Segar - RTSJMKQ (Reuters)

Matthew Rozsa
Advertisement:
Bernie Sanders (Reuters/Jim Urquhart)

Matthew Rozsa
Senate Banking Committee member Sen. Elizabeth Warren questions Wells Fargo Chief Executive Officer John Stumpf, on Capitol Hill in Washington, Tuesday, Sept. 20, 2016, during the committee's hearing. (AP)

Robert Reich
Mylan NL CEO Heather Bresch holds EpiPens during a House Oversight and Government Reform Committee hearing on the Rising Price of EpiPens at the Capitol, September 21, 2016. (Reuters/Yuri Gripas)

Inside the EpiPen's show trial

Gary Legum
EpiPen 2-Pak (EpiPen.com)

Paul Buchheit - Alternet
Advertisement:
EpiPen 2-Pak (EpiPen.com)

Drugs and privilege

Michael Winship - BillMoyers.com
EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016. REUTERS/Jim Bourg - RTX2MWU3 (Reuters/Jim Bourg)

Martha Rosenberg - Alternet
EpiPen 2-Pak (EpiPen.com)

Scott Eric Kaufman
EpiPen 2-Pak (EpiPen.com)

Scott Eric Kaufman
Advertisement: